Loading...
NPI 1922082072 · Louisville, KY · Ophthalmology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Inder Singal is a ophthalmology physician provider located in Louisville, Kentucky. This profile covers 28 Medicare and 7 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Inder Singal |
| Address | 1935 Bluegrass Ave |
| City | Louisville |
| State | KY |
| ZIP | 40215 |
| Taxonomy | Ophthalmology Physician |
| NPI Enumerated | December 2, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $4M |
| Medicaid | $151.3K |
INDER SINGAL is an ophthalmology physician whose billing profile is dominated by retinal care workflows: Medicare shows heavy use of intravitreal injections and diagnostic retinal imaging with J0178 (Injection, aflibercept) generating $2.6M (65.1% of Medicare revenue) and 92134 (retinal imaging) appearing with 3.4K claims and $87.2K in Medicare revenue; Medicaid also reflects retinal imaging activity via 92134 with 1.4K claims and $44.7K. The mix of high-volume injectable biologic codes alongside advanced imaging codes and retinal surgical CPTs (e.g., 67028) indicates a practice organized around medical retina services and procedural intravitreal therapy delivery.
Medicare revenue is highly concentrated: the precomputed top 3 Medicare codes account for 79.5% of this provider's total Medicare revenue, primarily driven by J0178 ($2.6M, 65.1%), followed by J2777 ($353.2K, 8.9%) and 67028 ($222.7K, 5.6%). This concentration means the provider’s Medicare financial performance is heavily dependent on anti-VEGF/retina procedural volume rather than diversified office-only E/M billing.
Medicaid revenue is similarly concentrated: the precomputed top 3 Medicaid codes account for 79.5% of this provider's total Medicaid revenue, led by 99214 ($48.8K, 32.2%), 92134 ($44.7K, 29.6%), and 67028 ($26.8K, 17.7%). Unlike Medicare, Medicaid dollars come proportionally more from E/M and imaging in this profile, though the presence of 67028 shows intravitreal injections contribute materially to state-program revenue as well.
Payer mix is strongly Medicare-centric: total Medicare revenue of $4M dwarfs Medicaid revenue of $151.3K, indicating the practice is effectively Medicare-driven in scale and margins. Analysts should treat Medicaid as a modest supplementary revenue stream rather than a primary payer for this provider.
National competitive standing on key Medicare codes is elevated: J0178 ranks #83 of 3204 providers nationally (97th percentile) and is described as notably above typical national volume, 92134 ranks in the 99th percentile and is labeled an extreme outlier, and J7312 ranks in the 95th percentile (notably above typical). These high ranks position the provider as a high-volume national performer for aflibercept administration and retinal imaging relative to peers.
By contrast, the provider’s Medicaid competitiveness is more modest and variable in-state: 92134 ranks #12 of 74 providers in-state (85th percentile) showing relatively strong imaging volume, while 67028 (injections) ranks #22 of 31 in-state (30th percentile) and 99214 ranks in the 56th percentile — overall a stronger imaging presence than injection dominance within the Medicaid population. This suggests the provider captures retinal diagnostic activity in Medicaid but is not a leading statewide injector for Medicaid patients.
Tenure is long and suggests operational stability: the NPI was enumerated on 2005-12-02 (~21 years ago), indicating more than two decades of enrollment in federal programs. That longevity supports expectations of established referral relationships and mature clinical workflows for retinal care.
Several statistical flags point to concentrated, high-volume activity that may matter for contracting and capacity planning: codes characterized as "extreme outlier" or "notably above typical" include 92134 (Medicare, extreme outlier), J0178 (Medicare, notably above typical), and 99214 (Medicare, extreme outlier). These labels, together with the 79.5% top-3 concentration on both payers, highlight both revenue dependence on a few codes and areas where utilization is atypically high relative to peers.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
28 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 3,820 | $680 | $2.6M |
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 12,180 | $30 | $353.2K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 2,530 | $90 | $222.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,790 | $80 | $148.7K |
| J2778 | Injection, ranibizumab, 0.1 mg | 770 | $180 | $138.5K |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 580 | $160 | $92.4K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 3,350 | $30 | $87.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 980 | $50 | $52.2K |
| 67108 | The provider repairs a detached retina using heat produced by a laser beam or by freezing the tissues. He may attach a scleral buckle to simplify the passage of fluid through and behind the retina or… | 50 | $840 | $38.5K |
| J3490 | Unclassified drugs | 50 | $660 | $35.6K |
Showing 1–10 of 28
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 28 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
28 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J0178 | 2 | 40 | 870 | $690 | $858.5K |
| J2777 | 13 | 30 | 11,040 | $30 | $399.1K |
| J2778 | 7 | 20 | 700 | $180 | $148.3K |
| 67028 | 2 | 50 | 650 | $90 | $72.9K |
| J7312 | 1 | 10 | 190 | $160 | $43.9K |
| 67036 | 4 | 20 | 20 | $910 | $28.1K |
| J3490 | 6 | 10 | 50 | $370 | $27.2K |
| 67040 | 6 | 10 | 20 | $1,030 | $24.7K |
| 67041 | 10 | 10 | 20 | $1,020 | $24.5K |
| 67042 | 6 | 10 | 20 | $1,170 | $23.4K |
Showing 1–10 of 28
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
7 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 860 | $60 | $48.8K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 1,400 | $30 | $44.7K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 160 | $170 | $26.8K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 710 | $40 | $26.1K |
| 92250 | Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,… | 80 | $40 | $3.1K |
| J9035 | Injection, bevacizumab, 10 mg | 20 | $70 | $1.1K |
| 92133 | The provider performs computerized diagnostic imaging of the optic nerve in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both… | 30 | $30 | $680 |
How this provider's Medicaid billing volume and revenue compare to other Kentucky providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Kentucky median
7 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,866 | 3,340 | 1,020 | $30 | $296K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,077 | 2,460 | 580 | $40 | $245K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 22 | 30 | 350 | $70 | $165.3K |
| J9035 | Injection, bevacizumab, 10 mg | 17 | 20 | 120 | $130 | $96.1K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 12 | 70 | 210 | $20 | $29.2K |
| 92250 | Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,… | 81 | 160 | 80 | $20 | $10.5K |
| 92133 | The provider performs computerized diagnostic imaging of the optic nerve in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both… | 38 | 50 | 60 | $30 | $5.8K |
Other providers in the same ZIP code as Inder Singal, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Landmark Recovery Of Kentucky LLC | KY | Substance Abuse Rehabilitation Facility | $0 | $21.1M |
| Behavior Analysts Of Texas, LLC | KY | Behavior Analyst | $0 | $13.1M |
| Vip Imaging, PLLC | KY | Diagnostic Radiology Physician | $0 | $5.3M |
| Steven Bloom | KY | Ophthalmology Physician | $2.3M | $232K |
| Janelle Adeniran | KY | Ophthalmology Physician | $1.8M | $3.4K |
| Lewis Hargett | KY | Physical Medicine & Rehabilitation Physician | $103.6K | $685.6K |
| Denise Dickinson | KY | Dermatology Physician | $632.7K | $0 |
| John Millin | KY | Ophthalmology Physician | $457.5K | $43.5K |
| Adam Mueller | KY | Optometrist | $141.5K | $277.7K |
| Lawrence Tenkman | KY | Ophthalmology Physician | $383.7K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.